The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes

被引:0
|
作者
Y. Çakıroğlu
F. Vural
B. Vural
机构
[1] Kocaeli University School of Medicine,Obstetrics and Gynecology Department
[2] Obstetrics and Gynecology Clinic,undefined
[3] Haydarpaşa Numune Training and Research Hospital,undefined
关键词
Polycystic ovary syndrome; Inflammation; Neutrophil/lymphocyte ratio; Platelet/lymphocyte ratio; Mean platelet volume; IVF outcomes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:899 / 907
页数:8
相关论文
共 50 条
  • [21] Obesity and polycystic ovary syndrome
    Barber, Thomas M.
    Franks, Stephen
    CLINICAL ENDOCRINOLOGY, 2021, 95 (04) : 531 - 541
  • [22] Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity
    Kahal, H.
    Aburima, A.
    Ungvari, T.
    Rigby, A. S.
    Dawson, A. J.
    Coady, A. M.
    Vince, R. V.
    Ajjan, R. A.
    Kilpatrick, E. S.
    Naseem, K. M.
    Atkin, S. L.
    CLINICAL ENDOCRINOLOGY, 2013, 79 (02) : 252 - 258
  • [23] Obesity and polycystic ovary syndrome
    Armanini, D.
    Giorgino, F. L.
    Fiore, C.
    GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2010, 32 (05): : 273 - 277
  • [24] Obesity and the polycystic ovary syndrome
    A Gambineri
    C Pelusi
    V Vicennati
    U Pagotto
    R Pasquali
    International Journal of Obesity, 2002, 26 : 883 - 896
  • [25] Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome
    Guzel, Eda Celik
    Celik, Cem
    Abali, Remzi
    Kucukyalcin, Volkan
    Celik, Elcin
    Guzel, Murat
    Yilmaz, Murat
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (06) : 419 - 422
  • [26] The influence of obesity on ICSI outcomes in women with polycystic ovary syndrome
    Ozgun, M. T.
    Uludag, S.
    Oner, G.
    Batukan, C.
    Aygen, E. M.
    Sahin, Y.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2011, 31 (03) : 245 - 249
  • [27] Polycystic ovary syndrome accompanied by hypertension and obesity: A premature association?
    Popova, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 374 - 374
  • [28] Evaluation of inflammatory markers in patients diagnosed with polycystic ovary syndrome (PCOS) Inflammatory markers in PCOS
    Uyanik, Muzeyyen
    Simsek, Deniz
    Temur, Muzaffer
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2021, 12 (11): : 1283 - 1287
  • [29] A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome
    Heijnen, EMEW
    Eijkemans, MJC
    Hughes, EG
    Laven, JSE
    Macklon, NS
    Fauser, BCJM
    HUMAN REPRODUCTION UPDATE, 2006, 12 (01) : 13 - 21
  • [30] Is the polycystic ovary syndrome the causative of the increase in inflammatory markers and metabolic risk?
    Rey-Roldan, Estela
    Perez Lana, Maria Belen
    Galluzzo, Liliana
    Blanco, Georgina
    Onetto, Claudia
    Straminsky, Vanesa
    Patricio Nolting, Manuel
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (02) : 141 - 144